ISIS PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: ISIS PHARMACEUTICALS INC, 10-Q, EX-10.33, 2000-08-14
Next: CURATIVE HEALTH SERVICES INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION DERIVED FROM THE COMPANY'S
CONDENSED BALANCE SHEET AS OF JUNE 30, 2000 (UNAUDITED) AND CONDENSED STATEMENTS
OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 2000 (UNAUDITED) AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          62,043
<SECURITIES>                                    58,291
<RECEIVABLES>                                    4,644
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               126,188
<PP&E>                                          22,596
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 177,024
<CURRENT-LIABILITIES>                           12,762
<BONDS>                                         94,504
                                0
                                     24,638
<COMMON>                                            28
<OTHER-SE>                                      69,758
<TOTAL-LIABILITY-AND-EQUITY>                   177,024
<SALES>                                              0
<TOTAL-REVENUES>                                11,039
<CGS>                                                0
<TOTAL-COSTS>                                   31,831
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,236
<INCOME-PRETAX>                               (33,216)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (33,216)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (33,216)
<EPS-BASIC>                                      (.95)
<EPS-DILUTED>                                    (.95)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission